• Making mRNA Delivery Measurable

  2026-08-29

  Translational mRNA research increasingly depends on separating delivery, intracellular localization, and protein expression rather than treating fluorescence as a single endpoint. This thought-leadership perspective connects the mechanistic lessons of targeted mRNA nanoparticles in ischemic stroke with a practical dual-readout strategy using ARCA Cy5 EGFP mRNA (5-moUTP).

• FPH1 (BRD-6125) Hepatocyte Workflow Guide

  2026-08-28

  FPH1 (BRD-6125) supports a function-first strategy for expanding primary human hepatocytes and improving iPSC-derived hepatocyte-like cells. This guide translates the product profile into practical dosing, assay design, troubleshooting, and a carefully bounded connection to light-regulated gene-expression research.

• mCherry mRNA for Nanoparticle Assay Design

  2026-08-28

  Learn how mCherry mRNA can function as more than a fluorescent reporter: it can help separate nanoparticle loading, cellular uptake, translation, and transcript persistence. This practical framework highlights how EZ Cap™ mCherry mRNA supports reproducible delivery and formulation decisions.

• Meropenem Trihydrate in Resistance Research

  2026-08-27

  Learn how Meropenem trihydrate supports reproducible susceptibility testing, resistance phenotyping, and metabolomics-informed assay design. This workflow-focused guide connects a broad-spectrum carbapenem antibiotic to practical controls, sample-handling decisions, and troubleshooting for bacterial infection treatment research.

• N-MYC–eIF4G1 Axis in inv(16) AML

  2026-08-27

  A 2024 Science Advances study identifies an essential MYCN enhancer and establishes the N-MYC/eIF4G1 pathway as a survival circuit in inv(16) acute myeloid leukemia. Its combined pharmacologic, transcriptional, functional, and patient-derived xenograft evidence clarifies how CBFβ-SMMHC-associated signaling sustains leukemia and suggests measurable endpoints for acute myeloid leukemia research.

• Cas9 mRNA–gRNA Delivery for LGMN Editing

  2026-08-26

  This Scientific Reports study developed a lipid nanoparticle strategy for co-delivering Cas9 mRNA and guide RNA to edit the metastasis-associated LGMN gene in breast cancer models. Its findings connect transient RNA-based genome editing with impaired lysosomal function and reduced cancer-cell migration and invasion, while also identifying practical considerations for guide-RNA and Cas9 mRNA production.

• Epacadostat (INCB024360) in Whole-Blood IDO1 Assays

  2026-08-26

  Epacadostat (INCB024360) converts standardized whole-blood stimulation into a practical model for linking IDO1 activity with cytokine and tryptophan-catabolism changes. This guide covers assay setup, checkpoint-inhibitor combination testing, dose selection, and troubleshooting while separating validated product properties from workflow recommendations.

• JXY, TLR4, and Macrophage Polarization in CAC

  2026-08-25

  The reference study shows that Jiedu Xiaozheng Yin suppresses colitis-associated colorectal cancer in mice while shifting intestinal macrophages toward an M1-like phenotype through TLR4-associated signaling. Its integrated in vivo, cellular, transcriptional, and pharmacological design connects tumor burden with immune-state remodeling and provides a useful framework for investigating inflammation-driven colorectal cancer.

• Alternariol (AOH) in Fibrosis Research

  2026-08-25

  Alternariol (AOH) enables controlled studies of hepatic stellate cell activation, CYP1A1/CYP1A2 metabolism, apoptosis, and foodborne toxin biology. This workflow-focused guide shows how to prepare, dose, compare, and troubleshoot AOH experiments while separating product handling recommendations from findings reported in the reference study.

• Inside-Out Engineering of RNA Nanoparticles

  2026-08-24

  The ACS Nano study develops a systematic framework for engineering ternary polyelectrolyte nanoparticles by tuning PEGylated polyanion chemistry around self-amplifying RNA polyplexes. Combining stability screening, neutron scattering, cell studies, and molecular dynamics, the authors show that a moderate balance of hydrophobicity and charge density can couple extracellular stability with intracellular RNA release.

• Cy5-UTP: Mechanism, RNA Labeling & Workflow

  2026-08-24

  Cy5-UTP, also called Cyanine 5-uridine triphosphate, is a fluorescent UTP analog for T7 polymerase–mediated RNA probe synthesis. Its documented 650/670 nm excitation and emission maxima support direct fluorescence detection in FISH, multicolor analysis, and dual-color expression arrays.

• Licoricidin in HCC: PI3K/AKT, Growth, and Metastasis

  2026-08-23

  A February 2026 study reports that the licorice-derived prenylated isoflavone licoricidin inhibits hepatocellular carcinoma growth and metastatic behavior in cell and mouse models. Its value lies in connecting S-phase arrest, apoptosis, epithelial–mesenchymal transition suppression, and reduced PI3K/AKT signaling, while also highlighting the need for stronger target-validation and translational studies.

• Intravesical p21 mRNA-LNP Therapy in Bladder Cancer

  2026-08-22

  This FASEB Journal study develops chemically modified p21 mRNA encapsulated in lipid nanoparticles for localized intravesical treatment of bladder cancer. The approach restored nuclear p21, suppressed tumor-associated cell-cycle activity, and reduced orthotopic tumor growth while limiting systemic distribution in mice.

• OTUD3–SLC7A11 Axis in Sunitinib Resistance

  2026-08-22

  The reference study identifies OTUD3-mediated stabilization of SLC7A11 as a mechanism that protects clear cell renal cell carcinoma from sunitinib-induced ferroptosis. Its findings connect deubiquitination, cystine utilization, glutathione-dependent redox control, lipid peroxidation, and therapeutic resistance, while suggesting that OTUD3 is a potential sensitization target.

• Paroxetine Mesylate: From SERT to CRC Assays

  2026-08-21

  Paroxetine Mesylate is more than a Selective serotonin reuptake inhibitor: it is a valuable probe for connecting SERT pharmacology with MET–ERBB3 signaling in colorectal cancer models. This article translates the key evidence into practical assay-design decisions while separating established findings from exploratory interpretation.

8009 records 1/534 page Next 12345 下5页 Last page